Immunovia AB (publ) (FRA:1YR)
Germany · Delayed Price · Currency is EUR 0.0039
-0.0012 (-23.53%)
At close: Nov 28, 2025
Immunovia AB Company Description
Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden.
It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual.
Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Immunovia AB (publ)
| Country | Sweden |
| Founded | 2007 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 9 |
| CEO | Jeff Borcherding |
Contact Details
Address: Medicon Village Lund, 223 63 Sweden | |
| Phone | 46 4 62 75 60 00 |
| Website | immunovia.com |
Stock Details
| Ticker Symbol | 1YR |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Jeff Borcherding | Chief Executive Officer |